News: BNF correction
The section on bisphosphonates in the latest edition of the British National Formulary (no. 42) contains a misleading statement in its discussion of disodium etidronate.
It states that disodium etidronate can impair bone mineralisation (section 6.6.2, p364). Although this is true when giving the drug continously to treat Pagets disease, the text does not say that it is of little relevance when the drug is used intermittently for the treatment and prevention of osteoporosis.
The electronic versions of the BNF have been corrected and the text will be reworded for the next edition of the book.
Citation: Electronicjuice URI: 20005031
Recommended from Pharmaceutical Press
Now available as a 1 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£138.50
Now available as a 2 year print subscription to both the BNF and BNFC, ensuring you have the latest medicines information as it publishes and at a greatly reduced price.£262.50
BNF 77 (March 2019) is your essential reference book for prescribing, dispensing, and administering medicines.£53.95
BNF 78 (September 2019) is your essential reference book for prescribing, dispensing, and administering medicines.£59.95
The BNFC contains essential practical information for all healthcare professionals involved in prescribing, dispensing, monitoring and administration of medicines to children.£59.95